SALEM INVESTMENT COUNSELORS INC

Position in CRSP — CRISPR Therapeutics AG

CIK 884423 WINSTON-SALEM, NC

Position in CRSP

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$29,178

+$3,729 QoQ

Shares Held

535

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#34

of 71 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SALEM INVESTMENT COUNSELORS INC holds $2,462,425 across 22 Biotechnology names. CRSP ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	100,000	$1,782,000
2	VRTX	Vertex Pharmaceuticals Inc / Ma	494	$245,384
3	FTRE	Fortrea Holdings Inc.	5,746	$99,980
4	VKTX	Viking Therapeutics, Inc.	2,288	$89,254
5	INCY	Incyte Corp	779	$88,307
6	AUPH	Aurinia Pharmaceuticals Inc.	2,675	$45,394
7	AKTS	Aktis Oncology, Inc.	1,000	$32,230
8	CRSP	CRISPR Therapeutics AG This page	535	$29,178

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,178	535	0.0%	Shares	Sole	2026-07-14
2026-03-31	$25,449	535	+77.2%	Shares	Sole	2026-04-29
2025-09-30	$19,572	302	0.0%	Shares	Sole	2025-10-07
2025-06-30	$14,689	302	-64.6%	Shares	Sole	2025-07-08
2025-03-31	$28,993	852	0.0%	Shares	Sole	2025-04-16
2024-12-31	$33,534	852	-52.1%	Shares	Sole	2025-01-13
2024-09-30	$83,483	1,777	+0.1%	Shares	Sole	2024-10-15
2024-06-30	$95,867	1,775	0.0%	Shares	Sole	2024-07-11
2024-03-31	$120,984	1,775	-1.7%	Shares	Sole	2024-04-11
2023-12-31	$112,993	1,805	0.0%	Shares	Sole	2024-01-16
2023-09-30	$81,928	1,805	+5916.7%	Shares	Sole	2023-10-04
2023-06-30	$1,684	30	—	Shares	Sole	2023-07-19
No filing history on record for this holder in this stock.